IDH3A and neoplasm: Mounting evidence shows that the isocitrate dehydrogenase (IDH) mutation is crucial for the alterations in tumor immunological microenvironment, as indicated by suppression of tumor-infiltrating lymphocytes, natural killer cells and cytotoxic T cells (Bunse et al., 2018; Ren et al., 2019).